CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE; VALSARTAN
✉ Email this page to a colleague
All Clinical Trials for amlodipine besylate; valsartan
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02060019 ↗ | Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects | Completed | CJ HealthCare Corporation | Phase 1 | 2014-03-01 | This study is designated to evaluate the pharmacokinetic interactions of amlodipine besylate, valsartan and rosuvastatin in healthy male volunteers. |
NCT02060019 ↗ | Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects | Completed | HK inno.N Corporation | Phase 1 | 2014-03-01 | This study is designated to evaluate the pharmacokinetic interactions of amlodipine besylate, valsartan and rosuvastatin in healthy male volunteers. |
NCT02069821 ↗ | Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects | Completed | CJ HealthCare Corporation | Phase 1 | 2014-03-01 | The purpose of the study is to assess the pharmacokinetic interactions between amlodipine besylate/valsartan and atorvastatin single or co-administered in healthy volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for amlodipine besylate; valsartan
Condition Name
Clinical Trial Locations for amlodipine besylate; valsartan
Clinical Trial Progress for amlodipine besylate; valsartan
Clinical Trial Phase
Clinical Trial Sponsors for amlodipine besylate; valsartan
Sponsor Name